Stock Analysis on Net

Illumina Inc. (NASDAQ:ILMN)

This company has been moved to the archive! The financial data has not been updated since November 5, 2021.

Cash Flow Statement
Quarterly Data

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Illumina Inc., consolidated cash flow statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Oct 3, 2021 Jul 4, 2021 Apr 4, 2021 Dec 31, 2020 Sep 27, 2020 Jun 28, 2020 Mar 29, 2020 Dec 29, 2019 Sep 29, 2019 Jun 30, 2019 Mar 31, 2019 Dec 30, 2018 Sep 30, 2018 Jul 1, 2018 Apr 1, 2018 Dec 31, 2017 Oct 1, 2017 Jul 2, 2017 Apr 2, 2017 Dec 31, 2016 Oct 2, 2016 Jul 3, 2016 Apr 3, 2016
Consolidated net income 317 186 147 257 179 47 173 239 234 293 224 197 188 200 197 57 153 120 348 108 117 116 87
Depreciation expense 46 41 41 42 39 38 37 38 37 39 37 40 35 35 30 29 29 26 26 25 23 22 21
Amortization of intangible assets 19 8 7 8 8 8 7 7 10 10 10 10 10 10 9 10 12 12 12 13 13 13 13
Share-based compensation expense 509 80 67 78 61 16 39 49 46 48 51 47 48 50 48 41 34 39 50 27 35 32 35
Accretion of debt discount on convertible senior notes 7 9 10 11 10 9 10 10 9 13 14 15 10 8 8 7 8 8 7 7 7 7 8
Incremental tax benefit related to share-based compensation 19 (26) (25) (59)
Deferred income taxes 75 (77) (79) 67 3 76 (29) 24 (19) 17 (11) 14 (10) (11) (11) 28 (13) (20) 86 36 30 34 (6)
Gain on previously held investment in GRAIL (900)
(Gains) losses on equity securities, net (41) (28) 72 (142) (59) (66) (3) 4 47 (102) (2) (21)
Gain on Helix contingent value right (30)
Payment of accreted debt discount (84)
Gain on deconsolidation (39) (15) (453)
(Gain) loss on derivative assets related to terminated acquisition (26) 9 12 95 8
Change in fair value of contingent consideration (7)
Impairment of intangible assets 23
Other (6) 2 (19) (19) (2) (10) (2) 9 (5) (2) (3) 4 6 (6) 3 3 (3) (2) (3) 2 4 (1)
Accounts receivable (64) (22) (39) (19) (82) 91 99 (29) (75) (10) 56 (81) (36) 1 11 (27) (13) (2) 16 (2) (8) 26 (13)
Inventory (18) (17) 8 44 19 (51) (24) 58 3 (10) (26) (13) (12) (11) (17) (6) (18) (10) 1 12 (1) (23) (17)
Prepaid expenses and other current assets (40) (1) 7 (5) (18) 17 (14) (3) (17) 6 (2) 6 3 (2) (6) 9 3 2 (5) (2) 8 (3)
Operating lease right-of-use assets and liabilities, net (4) (2) (3) (2) (2) (6) (1) (2) (2) (1)
Other assets (28) (3) (4) (8) (2) (12) (11) (1) (18) (3) (8) (4) (4) (1) (2) (2) (1) (1) (3) (2)
Accounts payable (40) 20 (8) 42 11 3 (16) 11 (3) 4 (47) 32 12 (1) 2 (2) 12 3 (3) 5 (15) 5 3
Accrued liabilities (81) 57 105 61 (27) 62 (103) 37 6 (17) (70) 58 28 35 (18) 25 15 (11) 52 33 (26) (1) (30)
Other long-term liabilities 14 (4) (9) 6 6 24 (19) (2) 5 (17) 11 (20) 5 137 4 15 4 6 2 4 4
Changes in operating assets and liabilities (261) 32 62 104 (95) 110 (46) 55 (92) (50) (107) (6) 5 3 (20) 119 9 (4) 71 49 (50) 14 (57)
Adjustments to reconcile net income to net cash provided by operating activities (589) 67 135 149 (26) 193 108 204 33 (150) (26) 103 104 95 58 237 82 58 (180) 173 33 101 (47)
Net cash provided by operating activities (272) 253 282 406 153 240 281 443 267 143 198 300 292 295 255 294 235 178 168 280 150 217 40
Maturities of available-for-sale securities 331 166 109 111 107 125 58 173 1,031 150 154 141 415 140 85 48 48 (9) 36 36 76
Purchases of available-for-sale securities (77) (1,045) (210) (291) (256) (250) (367) (276) (117) (507) (1,215) (539) (598) (383) (273) (25) (61) (215) (377) (218) (85)
Sales of available-for-sale securities 1,031 919 92 101 186 101 142 268 118 77 188 44 288 8 175 99 40 137 71 296 39
Proceeds from the deconsolidation of GRAIL 15 278
Cash (paid for) received derivative assets related to terminated acquisition 52 (132) (18)
Purchases of property and equipment (52) (44) (42) (62) (48) (39) (40) (57) (49) (47) (56) (65) (64) (77) (90) (76) (82) (69) (83) (82) (57) (68) (53)
Deconsolidation of Helix cash (29) (52)
Purchases of strategic investments (32) (9) (3) (12) (5) (107) (5) (2) (10) (3) (3) (3) (6) (3) (4) (18) (7) (5) (3) (4) (3)
Sales of strategic investments 136 84
Net cash paid for acquisitions (2,364) (80) (3) (95) (100) (18)
Cash paid for intangible assets (2) (11)
Net cash (used in) provided by investing activities (2,448) 3 1,376 (34) (65) (320) (135) (104) (218) 79 988 (348) (940) (537) 12 (315) (97) 35 163 (173) (341) 44 (44)
Payments on financing obligations (549) (1) (1) (1) (2) (2) (1) (5) (1) 5 1 4 (76)
Net proceeds from issuance of debt 988 735 5 3 2
Payments on convertible senior notes (490) (27)
Incremental tax benefit related to share-based compensation (19) 26 25 59
Common stock repurchases (281) (125) (142) (188) (63) (198) (63) (98) (103) (75) (75) (101) (136) (13) (100)
Taxes paid related to net share settlement of equity awards (422) (6) (24) (50) (3) (3) (35) (52) (4) (3) (23) (56) (3) (2) (13) (40) (4) (2) (22) (23) (4) (3) (70)
Proceeds from issuance of common stock 28 31 27 2 32 29 3 27 1 23 1 21 8 32 9 22 1 21 4 23
Contributions from noncontrolling interest owners 31 61 43 20 16 9 80
Payments on acquisition-related contingent consideration liability (3) (29)
Proceeds from early exercise of equity awards from a subsidiary 1 1 5
Net cash provided by (used in) financing activities (394) (496) 968 (331) (101) (143) (191) (115) (173) (549) (60) (154) 651 30 67 (109) (5) 24 (86) (163) 34 (63) (12)
Effect of exchange rate changes on cash and cash equivalents (2) 3 (3) 8 4 2 (6) 3 (4) (1) (4) 1 1 2 1 1 (4) (1) 2
Net increase (decrease) in cash and cash equivalents (3,116) (237) 2,623 49 (9) (221) (51) 227 (128) (327) 1,126 (202) 2 (216) 335 (129) 135 238 246 (60) (157) 197 (14)

Based on: 10-Q (reporting date: 2021-10-03), 10-Q (reporting date: 2021-07-04), 10-Q (reporting date: 2021-04-04), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-27), 10-Q (reporting date: 2020-06-28), 10-Q (reporting date: 2020-03-29), 10-K (reporting date: 2019-12-29), 10-Q (reporting date: 2019-09-29), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-30), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-07-01), 10-Q (reporting date: 2018-04-01), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-10-01), 10-Q (reporting date: 2017-07-02), 10-Q (reporting date: 2017-04-02), 10-K (reporting date: 2016-12-31), 10-Q (reporting date: 2016-10-02), 10-Q (reporting date: 2016-07-03), 10-Q (reporting date: 2016-04-03).

Cash flow statement item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Illumina Inc. net cash provided by operating activities decreased from Q1 2021 to Q2 2021 and from Q2 2021 to Q3 2021.
Net cash (used in) provided by investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Illumina Inc. net cash (used in) provided by investing activities decreased from Q1 2021 to Q2 2021 and from Q2 2021 to Q3 2021.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Illumina Inc. net cash provided by (used in) financing activities decreased from Q1 2021 to Q2 2021 but then slightly increased from Q2 2021 to Q3 2021.